| Gregory J Billman, MD | |
|
809 University Blvd E, Tuscaloosa, AL 35401-2029 | |
| (205) 759-7111 | |
| (205) 343-8549 |
| Full Name | Gregory J Billman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 27 Years |
| Location | 809 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417941972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 23986 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Alabama Anesthesia, Llc | 1052495843 | 6 |
| Tuscaloosa Anesthesia Associates Llc | 8628426178 | 18 |
News Archive
SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 1 days ago
| Entity Name | Anesthesia & Pain Management Of Tuscaloosa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932193406 PECOS PAC ID: 6204802705 Enrollment ID: O20040907000672 |
News Archive
SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 1 days ago
| Entity Name | West Alabama Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275718637 PECOS PAC ID: 1052495843 Enrollment ID: O20080304000168 |
News Archive
SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 1 days ago
| Entity Name | Tuscaloosa Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346934429 PECOS PAC ID: 8628426178 Enrollment ID: O20231122001846 |
News Archive
SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory J Billman, MD Po Box 934370, Atlanta, GA 31193-0001 Ph: (800) 897-6169 | Gregory J Billman, MD 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 759-7111 |
News Archive
SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 1 days ago
Dr. David C Nixon, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 Fax: 205-343-8549 | |
Bryan Hess Jones, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 800-232-5703 | |
Alexandru Georgescu, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-345-0970 | |
Dr. Leisa W Devenny, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 Fax: 205-343-8549 | |
Dr. Chauncey Herrington Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 Fax: 205-343-8549 | |
Jorge E. Rivas, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1400 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-5500 Fax: 205-502-5152 |